PathFinderOpen. Status: submitted! @stepelka

Nasza technologia w zasięgu Innovation Radar Nasza innowacyjna technologia „#VCSEL fabrication for Photonic Microphones”, opracowywana w ramach projektu PIONEAR, została „namierzona” przez radar Komisji Europejskiej i wyróżniona na platformie @EU_Commission ’s Innovation Radar. Platforma prezentuje przełomowe rozwiązania z projektów UE, a @LukasiewiczIMiF uzyskał tam status Key Innovator. Innowacja została również zidentyfikowana jako mająca potencjał do standaryzacji, co otwiera drogę do wsparcia przez EU Standardisation Booster (HSbooster.eu). Gratulujemy badaczom grupy Technologie #GaN, czujniki, struktury cienkowarstwowe i materiały porowate tego sukcesu! @PIONEAR_project – „A photonic microphone with better-than-human-ear sound quality” (HORIZON-EIC-2023-PATHFINDEROPEN) rozwija prototyp fotonicznego, miniaturowego mikrofonu opartego na zupełnie nowym czujniku chromometrycznym, integrującym elektronikę, MEMS i fotonikę. Efekt? Bardzo niski szum, programowalna kierunkowość, wysoka selektywność i szeroki zakres dynamiczny miniaturowego mikrofonu. To innowacja, która może zrewolucjonizować nie tylko elektronikę konsumencką i aparaty słuchowe, ale również autonomiczną robotykę, monitoring środowiskowy czy zaawansowane systemy czujników. Projektem kieruje Lumiary ze Szwecji. Wraz z partnerami: @TyndallInstitut (IE) · VIGO Photonics (PL)· Łukasiewicz–IMiF (PL)· @p_lodz_pl (PL) · Eastern Switzerland University of Applied Sciences – OST (CH) · @accelopment Schweiz (CH) tworzy unikalne konsorcjum, których badacze realizują przydzielone im zadania. Czym jest Innovation Radar? To inicjatywa Komisji Europejskiej, której celem jest identyfikacja najbardziej obiecujących innowacji i twórców w projektach finansowanych przez UE. Innovation Radar wskazuje technologie o wysokim potencjale rynkowym i promuje je wśród inwestorów oraz partnerów biznesowych. To już kolejna innowacja reprezentowana przez nas na Innovation Radarze – dowód naszego stałego zaangażowania i zdolności do tworzenia rozwiązań o europejskim znaczeniu. #HEU #Microtechnology #Photonics #Collaboration #Innovation

🧪 Partner spotlight: Prof. Ricardo Henriques @HenriquesLab At @ITQBNOVA, his team pioneers adaptive microscopy and AI-enhanced imaging. In #RTSuperES, they develop real-time feedback pipelines that merge biology with precision optics. #AIinScience #Microscopy #PathfinderOpen

🧠 Did you know? Machine learning algorithms in RT‑SuperES are trained to make on-the-fly decisions during live-cell imaging. This bridges acquisition & analysis, maximising efficiency and enabling discovery in real time. #AI #Microscopy #RTSuperES @EUeic #PathfinderOpen

⚙️ What makes the RT‑SuperES system unique? We combine live-cell super-resolution microscopy with real-time AI-based reconstruction, reducing processing time from hours to milliseconds. Enabling insights as they happen! #RTSuperES #AIinScience #Microscopy @EUeic #PathfinderOpen

➡Organizamos un taller, junto con @IRBBarcelona, de preparación de propuestas sobre la convocatoria @EUeic #PathfinderOpen 2025, donde abordamos, entre otros, aspectos de dimensión de género o buenas prácticas de #CienciaAbierta.

➡ El @EUeic abrió su convocatoria #EIC #PathfinderOPEN cuyo objetivo es desarrollar la base científica que sustente las tecnologías de vanguardia, apoyando las primeras fases de la investigación y el desarrollo científico, tecnológico o de alta tecnología.

📣 Ya está abierta la Convocatoria @EUeic #PathfinderOPEN 2025 dirigida a proyectos en etapas iniciales de I D con gran potencial para convertirse en las nuevas tecnologías más innovadoras y rompedoras. ➕ acortar.link/IaCsT0

Aquí presentamos la última newsletter del proyecto @Piezo4Spine en el que se muestran los logros científicos de este ambicioso planteamiento @HorizonteEuropa #PathfinderOpen @HNParaplejicos @idiscam @CSIC @gobjccm @icmm_csic piezo4spine.eu/wp-content/up…

Scientists develop light activated drugs to treat neuropathic pain A team of researchers led by the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be used to activate drugs in specific parts of the body through photopharmacology. This innovative approach involves modifying the chemical structure of a drug by adding a light-activated molecular switch, such as azobenzene. This allows the drug to be activated only when exposed to a specific colour of light, rather than in the dark. Based on these principles, a team of researchers led by the Institute for Bioengineering of Catalonia (IBEC) has developed photoswitchable derivatives of carbamazepine, an anti-epileptic drug widely used in medicine to combat some types of neuropathic pain, such as trigeminal neuralgia. These compounds, which have an analgesic effect when activated by light, are able to inhibit nerve signals locally and on demand. The derivatives synthesised by the researchers are activated at wavelengths corresponding to the amber colour, which allows them to pass through tissue and bone using conventional halogen lamps. The two synthesised compounds, carbazopine-1 and carbadiazocine, show photopharmacological activity, allowing the activity of hippocampal neurons and the locomotion of zebrafish larvae to be reversibly controlled by light. These in vivo experiments make it possible to observe anxiety-related behaviours reflected in sudden swimming movements. IBEC researcher Luisa Camerin, first author of the study, explains: "When we illuminate larvae that have uptaken these compounds with a certain wavelength, the drug is activated and the larvae move faster. If we change the wavelength, their movement slows down again, demonstrating the reversible effect of the compound on the nervous system. Carbadiazocine has also been shown to have analgesic properties: "In rat models developed in the laboratory of Esther Berrocoso at the University of Cadiz, we have observed that carbadiazocine has an analgesic effect on neuropathic pain without any signs of anaesthesia, sedation or toxicity. These results demonstrate a simple and convincing treatment with non-invasive illumination," explains Pau Gorostiza, ICREA research professor, principal investigator at IBEC and member of CIBER-BBN. Neuropathic pain is caused by lesions or diseases of the somatosensory system, such as lumbar radiculopathy ("sciatica"), diabetic neuropathy and chronic post-operative pain. The treatment of this type of pain often requires opioids, which are stronger analgesics than the usual NSAIDs - such as paracetamol and ibuprofen. However, their use is controversial due to their inconsistent efficacy, the need for high doses that can lead to tolerance and addiction, and systemic side effects such as constipation, nausea, dizziness and drowsiness. In this context, light-based therapies are becoming increasingly important in medicine because of their ability to target specific regions of the body, increasing treatment efficacy and reducing the side effects of systemic drugs. The team is already working on the next step in this project, which will involve activating drugs using infrared light, which penetrates deeper into tissue, and using portable light sources such as lasers or light-emitting diodes (LEDs). This study is part of the PHOTOTHERAPORT project, coordinated by the Institute for Bioengineering of Catalonia (IBEC). The project is funded by the prestigious Pathfinder Open programme of the European Innovation Council (EIC) and focuses on the development of luminescent implants and light-activated drugs for innovative neuromodulation therapies (HORIZON-EIC-2023 programme PATHFINDEROPEN-01, no. 101130883). PHOTOTHERAPORT is a consortium of 8 institutions from 4 countries with a budget of 3 million euros over 3 years to carry out the project. eurekalert.org/news-releases…

#EuropeosI3A 📣Sigue abierta la convocatoria del @EUeic #PathfinderOpen 2024: proyectos de cualquier temática con visión ambiciosa de desarrollo de tecnologías radicalmente nuevas con potencial de crear nuevos mercados. TRL 1-4. 📅Hasta 07/03/2024 ℹ️ eic.ec.europa.eu/eic-funding…

Komisja Europejska przyjęła program pracy #EIC na 2024 rok. Termin składania wniosków #PathfinderOpen już w marcu 2024! lnkd.in/dTBkpmGW @Access2EIC

Thrilled to be part of #Pathfinderopen #EIC project BRAINSTORM. More info: brainstorm-project.eu

Exciting postdoc opportunity in our lab within #Pathfinderopen #EIC project BRAINSTORM (brainstorm-project.eu). Check the job post here: euraxess.ec.europa.eu/jobs/1… #neuromodulation #magnetic_nanomaterials #neurobiology

@HNParaplejicos, parte fundamental del proyecto @Piezo4Spine , dotado con 3,5 millones € de @HorizonteEuropa para desarrollar y validar una nueva terapia para la lesión medular #PathfinderOpen @SanidadCLM @idiscam @CSIC @gobjccm @JulirosaNeuro @Picalagartos_ Concha Serrano

Today at the kick-off meeting of @Piezo4Spine @HorizonteEuropa #PathfinderOpen ! Time to start this new adventure with great partners and exciting science! @HNParaplejicos @idiscam @CSIC @gobjccm @icmm_csic @MaMBIOGroup

📢Thrilled to anounce that our European Project #Piezo4Spine #PathfinderOpen @HorizonteEuropa has just started!Happy to be the #WPleader of a fantastic team Elisa Dolado and @Picalagartos_, coordinated by C.Serrano @CSIC. More news soon! @idiscam @HNParaplejicos @SENC_ @gobjccm

Empezamos 2023 con nuestro proyecto Europeo #Piezo4Spine @PathfinderOpen @HorizonteEuropa donde desarrollaremos una nueva terapia para la lesión medular! Junto con Dra Dolado y @Picalagartos_ @HNParaplejicos, coordinado por @CSIC. @SENC_ @AgEInves @gobjccm elespanol.com/eldigitalcasti…

Reuniones bilaterales desde @aaconocimiento con #investigadores de @CanalUGR @OFPIUGR y con el NCP @EPelayo_CDTI @CDTI_innovacion para dinamizar la financiación de #HE #PathfinderOpen y #PathfinderChallenge en #Andalucía @Access2EIC. Gracias!!!

💫Happy to participate in this project, with IP @agusmihi @Enlightment_BCN! New #PathFinderOpen @EU_Commission @HorizonEU on Dynaic Spatio-Temporal Modulation of Light by #Phononic Architectures! ✨